Literature DB >> 5111305

In vitro susceptibility of atypical mycobacteria to rifampin.

A Molavi, L Weinstein.   

Abstract

Atypical mycobacteria (209 strains) were examined for susceptibility to rifampin by the proportion method by using Middlebrook 7H-10 agar. All strains of Mycobacterium kansasii and tap-water scotochromogens were inhibited by 0.25 to 1 mug of the drug per ml. Seventy-six per cent of M. scrofulaceum and 61% of M. intracellulare strains were susceptible to 4 mug/ml or less; 5% of the former and 8% of the latter were resistant to 16 mug/ml. All strains of M. gastri and M. triviale and most strains of M. terrae were sensitive to 1 to 4 mug/ml. Two strains of M. borstelense were both inhibited by 8 mug/ml. Nearly all strains of M. fortuitum were resistant to the drug. The results of this study suggest that rifampin may be a valuable agent for the treatment of many atypical mycobacterial infections.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5111305      PMCID: PMC377370          DOI: 10.1128/am.22.1.23-25.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  14 in total

1.  Rifampin and ethambutol in the retreatment of advanced pulmonary tuberculosis.

Authors:  A Gyselen; L Verbist; J Cosemans; L M Lacquet; E Vandenbergh
Journal:  Am Rev Respir Dis       Date:  1968-12

2.  The susceptibility of mycobacteria to rifamide and rifampicin.

Authors:  J Clark; A Wallace
Journal:  Tubercle       Date:  1967-06

3.  Experimental observations on the antimycobacterial activity of rifampin.

Authors:  T F Hobby GL LENERT; J Maier-Engallena
Journal:  Proc Soc Exp Biol Med       Date:  1969-06

4.  Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.

Authors:  L Verbist; A Gyselen
Journal:  Am Rev Respir Dis       Date:  1968-12

5.  Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.

Authors:  S Furesz; R Scotti; R Pallanza; E Mapelli
Journal:  Arzneimittelforschung       Date:  1967-05

6.  In vitro susceptibility of mycobacteria to rifampin.

Authors:  J K McClatchy; R F Waggoner; W Lester
Journal:  Am Rev Respir Dis       Date:  1969-08

7.  Rifampin: antibacterial activity in vitro and absorption and excretion in normal young men.

Authors:  P E Dans; R F McGehee; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1970-02       Impact factor: 2.378

8.  Rifampicin: a new orally active rifamycin.

Authors:  N Maggi; C R Pasqualucci; R Ballotta; P Sensi
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

9.  In vitro effect of rifampin on mycobacteria.

Authors:  V Lorian; M Finland
Journal:  Appl Microbiol       Date:  1969-02

10.  Antimycobacterial activity of rifampin under in vitro and simulated in vivo conditions.

Authors:  K D Stottmeier; G P Kubica; C L Woodley
Journal:  Appl Microbiol       Date:  1969-06
View more
  1 in total

Review 1.  Mycobacteriosis and Tuberculosis: Laboratory Diagnosis.

Authors:  Davood Azadi; Tahereh Motallebirad; Kazem Ghaffari; Hasan Shojaei
Journal:  Open Microbiol J       Date:  2018-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.